Indian Government Expands Medicine Price Control List To Include 39 More Drugs

by Shirley Johanna on  July 17, 2015 at 7:03 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

India has included 39 more drugs, under price control as part of its latest effort to make medicines affordable in the country, including the ones used to treat diabetes and digestive disorders.
Indian Government Expands Medicine Price Control List To Include 39 More Drugs
Indian Government Expands Medicine Price Control List To Include 39 More Drugs

As per the notification of National Pharmaceutical Pricing Authority (NPPA), the prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformin+Glimepiride have been fixed.

The latest move of the government will include medicines made by pharmaceutical companies, including Cadila Healthcare, Lupin, IPCA Laboratories, Abbott Laboratories and GlaxoSmithKline.

The new drugs join a price control list that covers more than 500 drugs. In the month of May, NPPA had capped the prices of 30 formulation packs, including the drugs that treat tuberculosis, diabetes and asthma.

The move comes after a parliamentary committee said in April that the scope of price control needed to be expended.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive